Novel 6-(1,2,3-tria
zol-4-yl)-5-[(2-(thia
zol-2-yl)hydra
zono)methyl]imida
zo[2,1-
b]thia
zoles
f="#jhet2610-eo-0015" rel="references:#jhet2610-eo-0015">,
f="#jhet2610-eo-0022" rel="references:#jhet2610-eo-0022 #jhet2610-eo-0023 #jhet2610-eo-0024 #jhet2610-eo-0025">, and
f="#jhet2610-eo-0027" rel="references:#jhet2610-eo-0027"> were prepared by reaction o
f thiosemicarba
zone
f="#jhet2610-eo-0012" rel="references:#jhet2610-eo-0012 #jhet2610-eo-0013"> with either hydra
zonoyl chloride
f="#jhet2610-eo-0014" rel="references:#jhet2610-eo-0014">, phenacylbromides
f="#jhet2610-eo-0016" rel="references:#jhet2610-eo-0016"> or
line-library/content/render" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="jhet2610-eo-0004">line-library/content/render" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="jhet2610-eo-0026">2-bromo-1-(5-methyl-1-p-tolyl-1H-1,2,3-triazol-4-yl)ethanone f="#jhet2610-eo-0026" rel="references:#jhet2610-eo-0026"> respectively. The new products were tested
for their antimicrobial activities using 96-well micro-plate assay, and compound
f="#jhet2610-eo-0015" rel="references:#jhet2610-eo-0015"> showed excellent antibacterial activities compared with Vancomycine (re
ference drugs), while compounds
f="#jhet2610-eo-0013" rel="references:#jhet2610-eo-0013"> and
f="#jhet2610-eo-0024" rel="references:#jhet2610-eo-0024"> exhibited good results against yeast. The minimum inhibitory concentration (MIC) was determined, and compound
f="#jhet2610-eo-0015" rel="references:#jhet2610-eo-0015"> showed the lowest MIC against Gram positive bacteria while compound
f="#jhet2610-eo-0013" rel="references:#jhet2610-eo-0013"> showed the lowest MIC against yeast.